Gaelle Bego-Le Bagousse, MSc

HEVA Head
Sanofi, Gentilly, France, France

Poster(s):

• (240) Estimating the Economic Impact of Dupilumab in Type 2 Inflammatory Disease: Cost Offset Analysis of Atopic Dermatitis with Comorbid Asthma in the US Healthcare System
  Wednesday, October 29, 2025